{"id":"https://openalex.org/W4362477227","doi":"https://doi.org/10.1158/1535-7163.22497882","title":"Supplementary Figure 3 from Crizotinib, a c-Met Inhibitor, Prevents Metastasis in a Metastatic Uveal Melanoma Model","display_name":"Supplementary Figure 3 from Crizotinib, a c-Met Inhibitor, Prevents Metastasis in a Metastatic Uveal Melanoma Model","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362477227","doi":"https://doi.org/10.1158/1535-7163.22497882"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.22497882","doi":"https://doi.org/10.1158/1535-7163.22497882","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22497882","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1535-7163.22497882","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079178474","display_name":"Oliver Surriga","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Oliver Surriga","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069187383","display_name":"Vinagolu K. Rajasekhar","orcid":"https://orcid.org/0000-0002-7364-2675","observed_orcids":["https://orcid.org/0000-0002-7364-2675"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vinagolu K. Rajasekhar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026962347","display_name":"Grazia Ambrosini","orcid":"https://orcid.org/0000-0002-3051-362X","observed_orcids":["https://orcid.org/0000-0002-3051-362X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Grazia Ambrosini","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045999796","display_name":"Yildrim Dogan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yildrim Dogan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035464945","display_name":"Ruimin Huang","orcid":"https://orcid.org/0000-0001-9369-0263","observed_orcids":["https://orcid.org/0000-0001-9369-0263"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ruimin Huang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5006913373","display_name":"Gary K. Schwartz","orcid":"https://orcid.org/0000-0003-1813-5061","observed_orcids":["https://orcid.org/0000-0003-1813-5061"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gary K. Schwartz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11328","display_name":"Ocular Oncology and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11328","display_name":"Ocular Oncology and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11149","display_name":"Veterinary Oncology Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/crizotinib","display_name":"crizotinib","score":1.0},{"id":"https://openalex.org/keywords/c-met-kinase-inhibitors","display_name":"c-Met inhibitor","score":0.9129999876022339},{"id":"https://openalex.org/keywords/uveal-melanoma","display_name":"uveal melanoma","score":0.9919999837875366},{"id":"https://openalex.org/keywords/metastasis-prevention","display_name":"metastasis prevention","score":0.843999981880188},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.8270000219345093},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.890999972820282}],"concepts":[{"id":"https://openalex.org/C2779422266","wikidata":"https://www.wikidata.org/wiki/Q5186964","display_name":"Crizotinib","level":4,"score":0.903380274772644},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.6712803244590759},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.604744553565979},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5825121402740479},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5094538331031799},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.4473174214363098},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4033341407775879},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3845076262950897},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.15227964520454407},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.08252805471420288},{"id":"https://openalex.org/C2776232967","wikidata":"https://www.wikidata.org/wiki/Q6743514","display_name":"Malignant pleural effusion","level":3,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1535-7163.22497882","doi":"https://doi.org/10.1158/1535-7163.22497882","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22497882","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1535-7163.22497882.v1","doi":"https://doi.org/10.1158/1535-7163.22497882.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22497882.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_3_from_Crizotinib_a_c-Met_Inhibitor_Prevents_Metastasis_in_a_Metastatic_Uveal_Melanoma_Model/22497882/1/files/39956235.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22497882","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figure_3_from_Crizotinib_a_c-Met_Inhibitor_Prevents_Metastasis_in_a_Metastatic_Uveal_Melanoma_Model/22497882","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.22497882","doi":"https://doi.org/10.1158/1535-7163.22497882","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22497882","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4362477227.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2163037808","https://openalex.org/W4392681118","https://openalex.org/W1963572063","https://openalex.org/W2065646627","https://openalex.org/W2042162550","https://openalex.org/W7017875239","https://openalex.org/W766341183","https://openalex.org/W2315358795","https://openalex.org/W4414887965","https://openalex.org/W3030759470"],"abstract_inverted_index":{"PDF":[0],"file":[1],"-":[2],"124K,":[3],"Supplementary":[4],"Figure":[5],"3:":[6],"Crizotinib":[7],"toxicity":[8],"in":[9],"uveal":[10],"melanoma":[11],"xenograft":[12],"studies.":[13]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}